Michael O’Neal

Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study

B. Cheson, B. Kahl, M. Munteanu, 2017, Leukemia & lymphoma.

Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials

C. Crim, D. Galkin, H. Ahmad, 2018, International journal of chronic obstructive pulmonary disease.

Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone

I. Jacobs, H. Gelderblom, R. Grimer, 2018, World Journal of Surgical Oncology.

Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance

D. Raunig, R. Walovitch, Colin G. Miller, 2021, Therapeutic Innovation & Regulatory Science.

Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials

R. V. Van Heertum, R. Messmann, B. Klencke, 2017, Drug design, development and therapy.

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

A. Vecchione, S. Wong, M. Sherman, 2017, Clinical Cancer Research.

Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials

R. V. Van Heertum, E. Berdougo, Michael O’Neal, 2015, Drug design, development and therapy.